• Edwards Lifesciences average ebitda margin for 2023 was 30.37%, a 11.69% decline from 2022.
• Edwards Lifesciences average ebitda margin for 2022 was 34.39%, a 6.47% decline from 2021.
• Edwards Lifesciences average ebitda margin for 2021 was 32.3%, a 36.11% increase from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.